Champions Oncology, Inc (CSBR) insider trading
Every open-market stock purchase and sale by Champions Oncology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Daniel Newman Mendelson (Director), $6.5K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent CSBR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Nov 5, 2025 | Scott R Tobin (10% owner) | Bought (not open market) | $173K |
| Nov 5, 2025 | Joel Ackerman (Director) | Bought (not open market) | $144K |
| Nov 5, 2025 | David Sidransky (Director) | Bought (not open market) | $144K |
| Nov 5, 2025 | Daniel Newman Mendelson (Director) | Bought (not open market) | $93.8K |
| Nov 5, 2025 | Philip P. Breitfeld (Director) | Bought (not open market) | $93.8K |
| Oct 30, 2025 | Joel Ackerman (Director) | Bought (not open market) | $198K |
Who's trading CSBR
- Scott R Tobin, 10% owner: other filings, last Nov 5, 2025
- Philip P. Breitfeld, Director: other filings, last Nov 5, 2025
- Joel Ackerman, Director: other filings, last Nov 5, 2025
- Daniel Newman Mendelson, Director: other filings, last Nov 5, 2025
- David Sidransky, Director: other filings, last Nov 5, 2025
Get free alerts when an insider at Champions Oncology, Inc files a new trade →